Cochlear deal sparks ACCC competition concerns

Yolanda RedrupRich List editor

Dec 1, 2022 – 12.02pm

Subscribe to gift this article

Gift 5 articles to anyone you choose each month when you subscribe.

Already a subscriber?

Cochlear’s proposed $170 million acquisition of a Danish hearing loss device maker is in the spotlight of the local competition watchdog, which believes it could substantially lessen competition in a “highly concentrated market”.

The Australian Competition and Consumer Commission announced on Thursday that it had “significant preliminary competition concerns” regarding Cochlear’s acquisition of Demant subsidiary Oticon Medical.

Yolanda Redrup is the editor of the AFR Rich List. She previously reported on technology, healthcare and Street Talk.